Lifastuzumab vedotin

Lifastuzumab vedotin (LIFA, DNIB0600A, RG-7599) is an antibody-drug conjugate (ADC) composed of a humanized anti-NaPi2b monoclonal antibody and an anti-mitotic cytotoxic agent, monomethyl auristatin E (MMAE) . Lifastuzumab vedotin is used in the treatment of platinum-resistant ovarian cancer.

Price Not Available 1mg*5 Lifastuzumab vedotin Supplier Page
Trivial name LIFA, DNIB0600A, RG-7599
Catalog Number D4010
CAS# 1401812-88-1
Size 1mg*5
Supplier Page http://www.selleckchem.com/products/lifastuzumab-vedotin.html